Authors: Swedberg, K Bergh, CH Dickstein, K McNay, J Steinberg, M

Citation: K. Swedberg et al., The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure, J AM COL C, 35(2), 2000, pp. 398-404

Authors: Dickstein, K Manhenke, C Aarsland, T McNay, J Wiltse, C Wright, T

Citation: K. Dickstein et al., The effects of chronic, sustained-release moxonidine therapy on clinical and neurohumoral status in patients with heart failure, INT J CARD, 75(2-3), 2000, pp. 167-176

Authors: Dickstein, K Manhenke, C Aarsland, T Kopp, U McNay, J Wiltse, C

Citation: K. Dickstein et al., Acute hemodynamic and neurohumoral effects of moxonidine in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, AM J CARD, 83(12), 1999, pp. 1638-1644

Authors: Hempel, G Karlsson, MO de Alwis, DP Toublanc, N McNay, J Schaefer, HG

Citation: G. Hempel et al., Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements, CLIN PHARM, 64(6), 1998, pp. 622-635